Bioregulator of the nervous tissue.
Composition: 1 ml of sterile solution contains; 0.1±0.01 mg of CaCI2 and 10-10-10-11 mg of protein-peptide complex.
Recommendations for use: in the rehabilitation period after strokes, injuries, bruises, concussions. after brain surgery, as well as weather-dependent patients before and during changes in atmospheric pressure. Prevents the development of discomfort associated with motion sickness of passengers in transport. In a particularly severe case, it is possible to take viorgon 2 several times in a row at the specified dosage at intervals of 10-15 minutes. In all cases, it is recommended that joint admission virgona 2 and virgona 1
Method of application: for 20-30 minutes before eating, 10-15 drops of the solution should be dropped under the tongue, washed down with a small amount of water. Take 3-5 times a day. The course of admission is 1-2 months. Taking the product is combined with taking other drugs, including medicines. The time interval between taking viorgon 2 and viorgon 1 or another drug is at least 10 minutes.
Contraindications: not detected. Overdose: is excluded. The effect of habituation: is missing.
Storage conditions: in a clean, dry, sun-protected place at a temperature of +5 to +25 °C and a relative humidity of not more than 75%.
Expiration date: 18 months from the date of manufacture.
Release form: 30 ml bottle (≈600 drops).